Immuno-Mycologics recalls

Immuno-Mycologics has 7 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 6 May 2026. 2 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls7since 2016

Last 12 months1reported

Class I00% of total

Ongoing2latest 6 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 1 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 1 0 0Jul 0 0

Severity split

Class I 0 0%Class II 7 100%Class III 0 0%

Why immuno-mycologics is recalled

Product types

By year

2026114%
2025114%
2022114%
2020114%
2018114%
2017114%
2016114%

Ongoing immuno-mycologics recalls

2 active

Reported	Class	Recall	Company	Reason	Where
6 May 2026Device	CLASS II	Immy, Myco DDR Trident, Bulk Neutralization Buffer B ( mL) recalled	Immuno-Mycologics	Sterility	Nationwide
26 Mar 2025Device	CLASS II	Candida ID Antigen, REAG, AG recalled by Immuno-Mycologics	Immuno-Mycologics	Other	Nationwide

All immuno-mycologics recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
6 May 2026Device	CLASS II	Immy, Myco DDR Trident, Bulk Neutralization Buffer B ( mL) recalled	Immuno-Mycologics	Sterility	Nationwide
26 Mar 2025Device	CLASS II	Candida ID Antigen, REAG, AG recalled by Immuno-Mycologics	Immuno-Mycologics	Other	Nationwide
9 Feb 2022Device	CLASS II	Cryptococcal Antigen Lateral Flow Assay, Immy recalled	Immuno-Mycologics	Potency & Assay	Nationwide
17 Jun 2020Device	CLASS II	Histoplasma Immunodiffusion (ID) Antigen recalled by Immuno-Mycologics	Immuno-Mycologics	Other	Nationwide
18 Jul 2018Device	CLASS II	Cryptococcal Antigen Lateral Flow Assay (CrAg LFA) recalled	Immuno-Mycologics	Potency & Assay	OK
8 Feb 2017Device	CLASS II	Cryptococcal Antigen Lateral Flow Assay (CrAg LFA) recalled	Immuno-Mycologics	Potency & Assay	Nationwide
29 Jun 2016Device	CLASS II	Histoplasma Yeast Complement Fixation Antigen Dilute recalled	Immuno-Mycologics	Mold	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.